These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


112 related items for PubMed ID: 11463489

  • 1. Strain variation in renal carcinogenesis by N-ethyl-N-hydroxyethylnitrosamine in F1 (Wistar-Fischer) rats.
    Takashima K, Ozono S, Nakanou I, Ota M, Tanaka M, Tani M, Hirao K, Hirao Y, Kuwashima S, Hiasa Y.
    Cancer Lett; 2001 Sep 20; 170(2):125-30. PubMed ID: 11463489
    [Abstract] [Full Text] [Related]

  • 2. Strain and sex differences in kidney carcinogenesis in rats treated with N-ethyl-N-hydroxyethylnitrosamine and uracil.
    Yamada Y, Takashi M, Sakata T, Nakano Y, Takagi Y, Hibi H, Miyake K.
    Hinyokika Kiyo; 1995 Oct 20; 41(10):781-7. PubMed ID: 8533674
    [Abstract] [Full Text] [Related]

  • 3. Basic lead acetate: promoting effect on the development of renal tubular cell tumors in rats treated with N-ethyl-N-hydroxyethylnitrosamine.
    Hiasa Y, Ohshima M, Kitahori Y, Fujita T, Yuasa T, Miyashiro A.
    J Natl Cancer Inst; 1983 Apr 20; 70(4):761-5. PubMed ID: 6572762
    [Abstract] [Full Text] [Related]

  • 4. Initiation-stage enhancement by uracil of N-ethyl-N-hydroxyethylnitrosamine-induction of kidney carcinogenesis in rats.
    Takashi M, Sakata T, Nakano Y, Takagi Y, Yamada Y, Hibi H, Miyake K, Shirai T.
    Cancer Lett; 1994 Dec 09; 87(2):151-7. PubMed ID: 7812934
    [Abstract] [Full Text] [Related]

  • 5. Potassium bromate enhances N-ethyl-N-hydroxyethylnitrosamine-induced kidney carcinogenesis only at high doses in Wistar rats: indication of the existence of an enhancement threshold.
    Wei M, Hamoud AS, Yamaguchi T, Kakehashi A, Morimura K, Doi K, Kushida M, Kitano M, Wanibuchi H, Fukushima S.
    Toxicol Pathol; 2009 Dec 09; 37(7):983-91. PubMed ID: 19833912
    [Abstract] [Full Text] [Related]

  • 6. Formation of 8-hydroxydeoxyguanosine in rat kidney DNA after administration of N-ethyl-N-hydroxyethylnitrosamine.
    Sato M, Kitahori Y, Nakagawa Y, Konishi N, Cho M, Hiasa Y.
    Cancer Lett; 1998 Feb 13; 124(1):111-8. PubMed ID: 9500199
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Experimental model of renal tumors in polycystic kidneys: effects of long-term 2-amino-4,5-diphenylthiazole administration in rats treated with N-ethyl-N-hydroxyethylnitrosamine.
    Tsumatani K, Nakagawa Y, Kitahori Y, Konishi N, Uemura H, Ozono S, Hirao Y, Okajima E, Hirao K, Hiasa Y.
    Toxicol Pathol; 1997 Feb 13; 25(4):363-71. PubMed ID: 9280119
    [Abstract] [Full Text] [Related]

  • 12. N-ethyl-N-hydroxyethylnitrosamine (EHEN)-induced renal and hepatocarcinogenesis in the tumor suppressor Tsc2 transgenic rat.
    Satake N, Miyagawa M, Sakurai J, Mitani H, Kobayashi T, Tamura H, Hino O.
    Cancer Lett; 2002 Oct 28; 184(2):157-63. PubMed ID: 12127687
    [Abstract] [Full Text] [Related]

  • 13. Sequential observations on the appearance of neoplastic lesions in the liver and kidney after treatment with N-ethyl-N-hydroxyethylnitrosamine followed by partial hepatectomy and unilateral nephrectomy.
    Tsuda H, Sakata T, Tamano S, Okumura M, Ito N.
    Carcinogenesis; 1983 Oct 28; 4(5):523-8. PubMed ID: 6850982
    [Abstract] [Full Text] [Related]

  • 14. The presence of alpha 2u-globulin is necessary for d-limonene promotion of male rat kidney tumors.
    Dietrich DR, Swenberg JA.
    Cancer Res; 1991 Jul 01; 51(13):3512-21. PubMed ID: 1711412
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Possible application to medium-term organ bioassays for renal carcinogenesis modifiers in rats treated with N-ethyl-N-hydroxyethylnitrosamine and unilateral nephrectomy.
    Hiasa Y, Konishi N, Nakaoka S, Nakamura M, Nishii S, Kitahori Y, Ohshima M.
    Jpn J Cancer Res; 1991 Dec 01; 82(12):1385-90. PubMed ID: 1778762
    [Abstract] [Full Text] [Related]

  • 20. Effect of polyphenon-60 on the development of renal cell tumors in rats treated with N-ethyl-N hydroxyethylnitrosamine.
    Yoshioka N, Hiasa Y, Cho M, Kitahori Y, Hirao K, Konishi N, Kuwashima S.
    Cancer Lett; 1999 Feb 08; 136(1):79-82. PubMed ID: 10211943
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.